PV pharm branch, vendor, cage 0U9U0
Ended Awarded Last action
- Contract number
- SPE2D826F13PS
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $760,964
Award facts
- Contract value 100% obligated
- $760,963.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $760,963.64 by the Defense Logistics Agency's Medical Supply Chain. The award, issued on January 13, 2026, with an ultimate completion date of January 14, 2026, utilizes a firm fixed-price contract structure with no set-aside designation. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999.99 million comprehensive global pharmaceutical support vehicle valued through December 2031. The IDC serves as the primary contracting mechanism for supplying a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains.
AmerisourceBergen's substantial federal contract portfolio and demonstrated capability to compete on a full and open basis have established the company as a critical vendor for federal medical procurement, particularly supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's ability to fulfill diverse pharmaceutical supply requirements through competitive delivery orders reflects its operational capacity to meet the evolving medical supply needs of military treatment facilities and veterans' healthcare programs. The DLA Medical Supply Chain's continued reliance on AmerisourceBergen underscores the vendor's importance in maintaining pharmaceutical supply chain integrity across federal defense and healthcare operations.
Quick answers
Who was awarded contract SPE2D826F13PS?
SPE2D826F13PS was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on January 13, 2026.
How much is contract SPE2D826F13PS worth?
The government has obligated $760,964 on SPE2D826F13PS.
Is contract SPE2D826F13PS an order under another contract?
Yes. SPE2D826F13PS is a delivery order under SPE2DX22D0020, an indefinite delivery contract.
Was contract SPE2D826F13PS competed?
The extent of competition for SPE2D826F13PS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award